These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 33494280)

  • 1. Artificial Intelligence for Histology-Based Detection of Microsatellite Instability and Prediction of Response to Immunotherapy in Colorectal Cancer.
    Hildebrand LA; Pierce CJ; Dennis M; Paracha M; Maoz A
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33494280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
    Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
    Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Agent Neoadjuvant Immunotherapy With a PD-1 Antibody in Locally Advanced Mismatch Repair-Deficient or Microsatellite Instability-High Colorectal Cancer.
    Pei F; Wu J; Zhao Y; He W; Yao Q; Huang M; Huang J
    Clin Colorectal Cancer; 2023 Mar; 22(1):85-91. PubMed ID: 36528470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence for detection of microsatellite instability in colorectal cancer-a multicentric analysis of a pre-screening tool for clinical application.
    Echle A; Ghaffari Laleh N; Quirke P; Grabsch HI; Muti HS; Saldanha OL; Brockmoeller SF; van den Brandt PA; Hutchins GGA; Richman SD; Horisberger K; Galata C; Ebert MP; Eckardt M; Boutros M; Horst D; Reissfelder C; Alwers E; Brinker TJ; Langer R; Jenniskens JCA; Offermans K; Mueller W; Gray R; Gruber SB; Greenson JK; Rennert G; Bonner JD; Schmolze D; Chang-Claude J; Brenner H; Trautwein C; Boor P; Jaeger D; Gaisa NT; Hoffmeister M; West NP; Kather JN
    ESMO Open; 2022 Apr; 7(2):100400. PubMed ID: 35247870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial Intelligence for Predicting Microsatellite Instability Based on Tumor Histomorphology: A Systematic Review.
    Park JH; Kim EY; Luchini C; Eccher A; Tizaoui K; Shin JI; Lim BJ
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting immunotherapy-sensitive subtype in gastric cancer using histologic image-based deep learning.
    Hinata M; Ushiku T
    Sci Rep; 2021 Nov; 11(1):22636. PubMed ID: 34811485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer.
    Trojan J; Stintzing S; Haase O; Koch C; Ziegler P; Demes M; Jelas I
    Oncologist; 2021 Dec; 26(12):e2110-e2114. PubMed ID: 34431576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
    Luchini C; Bibeau F; Ligtenberg MJL; Singh N; Nottegar A; Bosse T; Miller R; Riaz N; Douillard JY; Andre F; Scarpa A
    Ann Oncol; 2019 Aug; 30(8):1232-1243. PubMed ID: 31056702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities.
    Zhang X; Wu T; Cai X; Dong J; Xia C; Zhou Y; Ding R; Yang R; Tan J; Zhang L; Zhang Y; Wang Y; Dong C; Li Y
    Front Immunol; 2022; 13():795972. PubMed ID: 35371084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPsNet: An improved deep learning model for microsatellite instability high prediction in colorectal cancer from whole slide images.
    Lou J; Xu J; Zhang Y; Sun Y; Fang A; Liu J; Mur LAJ; Ji B
    Comput Methods Programs Biomed; 2022 Oct; 225():107095. PubMed ID: 36057226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Institutional Universal Microsatellite-Instability (MSI) Reflex Testing on Molecular Profiling Differences Between Younger and Older Patients with Colorectal Cancer.
    Altshuler E; Franke AJ; Skelton WP; Feely M; Wang Y; Lee JH; Read T; Terracina K; Lou XY; Dai Y; George TJ
    Clin Colorectal Cancer; 2023 Mar; 22(1):153-159. PubMed ID: 36319582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of machine learning in the prediction of deficient mismatch repair in patients with colorectal cancer based on routine preoperative characterization.
    Xu D; Chen R; Jiang Y; Wang S; Liu Z; Chen X; Fan X; Zhu J; Li J
    Front Oncol; 2022; 12():1049305. PubMed ID: 36620593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers.
    Liu F; Zhong F; Wu H; Che K; Shi J; Wu N; Fu Y; Wang Y; Hu J; Qian X; Fan X; Wang W; Wei J
    Oncologist; 2023 Mar; 28(3):e136-e144. PubMed ID: 36724040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of MSIntuit as an AI-based pre-screening tool for MSI detection from colorectal cancer histology slides.
    Saillard C; Dubois R; Tchita O; Loiseau N; Garcia T; Adriansen A; Carpentier S; Reyre J; Enea D; von Loga K; Kamoun A; Rossat S; Wiscart C; Sefta M; Auffret M; Guillou L; Fouillet A; Kather JN; Svrcek M
    Nat Commun; 2023 Nov; 14(1):6695. PubMed ID: 37932267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status.
    Cohen R; Hain E; Buhard O; Guilloux A; Bardier A; Kaci R; Bertheau P; Renaud F; Bibeau F; Fléjou JF; André T; Svrcek M; Duval A
    JAMA Oncol; 2019 Apr; 5(4):551-555. PubMed ID: 30452494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment.
    Taieb J; Svrcek M; Cohen R; Basile D; Tougeron D; Phelip JM
    Eur J Cancer; 2022 Nov; 175():136-157. PubMed ID: 36115290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers.
    Evrard C; Messina S; Sefrioui D; Frouin É; Auriault ML; Chautard R; Zaanan A; Jaffrelot M; De La Fouchardière C; Aparicio T; Coriat R; Godet J; Silvain C; Randrian V; Sabourin JC; Guimbaud R; Miquelestorena-Standley E; Lecomte T; Moulin V; Karayan-Tapon L; Tachon G; Tougeron D
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DeltaMSI: artificial intelligence-based modeling of microsatellite instability scoring on next-generation sequencing data.
    Swaerts K; Dedeurwaerdere F; De Smet D; De Jaeger P; Martens GA
    BMC Bioinformatics; 2023 Mar; 24(1):73. PubMed ID: 36859168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MSI/MMR-deficient tumor diagnosis: Which standard for screening and for diagnosis? Diagnostic modalities for the colon and other sites: Differences between tumors.
    Svrcek M; Lascols O; Cohen R; Collura A; Jonchère V; Fléjou JF; Buhard O; Duval A
    Bull Cancer; 2019 Feb; 106(2):119-128. PubMed ID: 30713006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.